Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,605 total articles
Exodus Movement, Inc., a US-based fintech company specializing in self-custodial finance, announced a long-term partnership with UFC as its inaugural Official Payments Partner. The collaboration includes prominent branding at UFC events, integration into broadcasts, and innovative fan activations, with high visibility during the upcoming UFC Freedo…
Optimi Health Corp. announced the successful completion of a GMP production run of its 5mg psilocybin capsules, currently prescribed for treatment-resistant depression in Australia. The company produced the capsules entirely in-house at its Health Canada-licensed facility, supporting both commercial patient access and upcoming clinical trials in th…
TG Therapeutics announced that CEO Michael S. Weiss will participate in a fireside chat at the Goldman Sachs 47th Annual Healthcare Conference to discuss the company's developments. The event will be webcast live for investors and media. TG Therapeutics is a biotechnology company focused on treatments for B-cell diseases and currently markets BRIUM…
QTREX Quantum Ltd. announced its upcoming presentation at Quantum.Tech World 2026, showcasing its proprietary Additively Manufactured Electronics (AME) based monolithic connectivity components designed to address critical cryogenic interconnect challenges in superconducting quantum systems. The company emphasizes its advanced capabilities in scalab…
Pluri Inc., a biotech innovator with a patented 3D cell-expansion platform, announced that its subsidiary Cellav has completed the U.S. cosmetic product listings for two regenerative aesthetic products, Regenativo+ and Placento+. This milestone enables imminent U.S. commercial launch targeting the rapidly growing regenerative aesthetics market. Cli…
Aveanna Healthcare Holdings Inc. announced the completion of its acquisition of Family First Homecare, a multi-state pediatric home care provider, for $175.5 million cash funded by cash on hand. This acquisition expands Aveanna's specialized care offerings and geographic footprint. In conjunction with the acquisition, Aveanna updated its full-year …
Quantum Cyber N.V., an autonomous defense technology company listed on Nasdaq, announced that it will assume direct manufacturing responsibilities for its licensed autonomous drone products, moving toward vertical integration. The company expanded its agreement with BP United, including a voting agreement aligning their governance interests and con…
Stardust Power Inc., a NASDAQ-listed U.S. lithium refinery developer, has been selected as an industrial partner in a Department of Energy-funded research project aimed at extracting lithium electrochemically from domestic waste streams such as wastewater and coal mine drainage. This collaboration supports the development of alternative domestic li…
FirstService Corporation has amended its normal course issuer bid (NCIB) to increase the maximum number of shares it can repurchase from 1.6 million to 4.1 million, representing up to 10% of its public float. The company also entered into an automatic share purchase plan (ASPP) with a designated broker to facilitate stock buybacks even during black…
Saia, Inc. disclosed increased Less-Than-Truckload (LTL) shipments and tonnage per workday for April and May 2026 compared to the same months in 2025, with shipment increases of 5.6% in April and 3.7% in May, and tonnage increases nearing 7-8% respectively. The data indicates improved freight activity and operational performance in the second quart…
Gilat Satellite Networks Ltd. announces that its defense division will present a broadened product portfolio supporting tactical unmanned platforms at Eurosatory 2026. Highlighting the launch is RaySat's new Viper Ka Electronically Steered Antenna, offering secure, low-latency communications with multi-orbit satellite capability designed for milita…
Howard Hughes Holdings announced the opening of The Park Ward Village®, the ninth residential tower in its Ward Village master-planned community in Honolulu. Nearly 97% pre-sold, the tower features 546 homes and over 30,000 square feet of retail and dining, expected to generate more than $700 million in GAAP revenue. The development strengthens How…
CorVel Corporation marks its 35th year on the Nasdaq, showcasing a history of strategic technology investments and operational excellence. The company emphasizes its strong financial position, commitment to innovation in healthcare management technologies, and readiness to continue delivering long-term value.
Microchip Technology has introduced its XpressConnect PCIe 6.0 and CXL 3.1 retimers designed to extend signal reach and reduce latency in AI data centers. These retimers support higher bandwidth connectivity and lower pin-to-pin latency, enabling better utilization of GPUs and AI accelerators in large-scale AI workloads. Integrated with Microchip's…
Lifecore Biomedical has signed a manufacturing services agreement with a leading ophthalmic disease solutions provider to conduct process development and technical transfer in preparation for potential commercial manufacturing of a next-generation injectable ophthalmic product. This marks the company's sixth addition to its late-stage pipeline in s…
Ocugen, Inc., a biotechnology company specializing in gene therapies for blindness diseases, announced its participation in several investor and industry conferences in June 2026. The company will present its innovative modifier gene therapy platform targeting inherited retinal diseases such as retinitis pigmentosa, Stargardt disease, and geographi…
Pasithea Therapeutics announced that the FDA has granted Orphan Drug Designation to its drug candidate PAS-004 for treating Amyotrophic Lateral Sclerosis (ALS). This designation supports the company's efforts in developing PAS-004 for ALS and potentially other MAPK pathway-related diseases, providing benefits such as tax credits, fee exemptions, an…
Opus Genetics, a clinical-stage biopharmaceutical company focused on gene therapies for inherited retinal diseases, announced a virtual R&D Science Forum on June 16, 2026. The forum will feature expert speakers discussing the company's multi-asset gene therapy pipeline, including upcoming clinical trials targeting RDH12, MERTK, and RHO mutations, r…
Entrada Therapeutics announced that an independent Data Monitoring Committee has recommended advancing to Cohort 2 at an increased dose of 10 mg/kg in their ongoing Phase 1/2 ELEVATE-45-201 clinical trial for ENTR-601-45, a potential treatment for Duchenne muscular dystrophy (DMD) patients amenable to exon 45 skipping. Cohort 1 participants have mo…
Bioventus Inc. announced that CFO Mark Singleton will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on June 8, 2026. The company, a leader in active healing innovations, will webcast the presentation live and replay it for investors. Bioventus focuses on products for pain treatment, restorative therapies, and surg…
BeyondSpring reported updated positive efficacy and safety results from its ongoing Phase 2 303 Study evaluating Plinabulin combined with pembrolizumab and docetaxel in metastatic non-small cell lung cancer patients who progressed after first-line immune checkpoint inhibitor therapy. The combination demonstrated favorable progression-free survival,…
Vera Therapeutics announced alignment with the U.S. FDA on an earlier eGFR analysis for the ORIGIN Phase 3 trial of atacicept, a therapy targeting BAFF and APRIL for adults with IgA nephropathy (IgAN). The revised analysis is now planned for Q3 2026, ahead of the previous 2027 timeline. Pending positive results, the company plans to submit a supple…
Victoria's Secret & Co. delivered a robust first quarter 2026 performance, with net sales rising 15% to $1.56 billion, surpassing guidance. Operating income increased significantly to $76 million from $20 million a year prior, supported by strong sales growth across key brands and improved gross margins. The company raised its full-year 2026 net sa…
Telix Pharmaceuticals Limited (TLX) and United Imaging Healthcare North America have signed a Memorandum of Understanding to collaborate on the integration of Telix's molecular imaging products with United Imaging's advanced scanner platforms and AI capabilities. The initial focus will be on the US evaluation of TLX101-Px, a PET imaging candidate u…
iBio has initiated dosing in its Phase 1 clinical trial for IBIO-600, a long-acting monoclonal antibody aimed at preserving muscle and improving body composition in adults with obesity. This milestone marks the company's transition to a clinical-stage biotech firm, showcasing progress in its AI-driven discovery platform and potential combination wi…
